The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines.
Dinis-Ribeiro M. et al, (2024), Gut, 73, 1607 - 1617
Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS).
Fischbach W. et al, (2024), Zeitschrift fur Gastroenterologie, 62, 261 - 321
Letter to the editor:Helicobacter pylorieradication – the proof is not in the symptoms
Bornschein J. et al, (2023), Gut, 72, 2387 - 2388
Low-cost and clinically applicable copy number profiling using repeat DNA.
Abujudeh S. et al, (2022), BMC genomics, 23
The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
Smet A. et al, (2022), Cellular and Molecular Gastroenterology and Hepatology, 13, 857 - 874
EGF and BMPs Govern Differentiation and Patterning in Human Gastric Glands
Wölffling S. et al, (2021), Gastroenterology, 161, 623 - 636.e16
Cost-effectiveness modelling of use of urea breath test for the management of Helicobacter pylori-related dyspepsia and peptic ulcer in the UK
Pritchard DM. et al, (2021), BMJ Open Gastroenterology, 8, e000685 - e000685
Helicobacter pylori induced gastric carcinogenesis - The best molecular model we have?
Link A. et al, (2021), Best Practice & Research Clinical Gastroenterology, 50-51, 101743 - 101743
Recent progress in the understanding of gastric cancer – Do patients experience a benefit yet?
Bornschein J. and Kupcinskas J., (2021), Best Practice & Research Clinical Gastroenterology, 50-51, 101740 - 101740
The complexity of cancer origins at the gastro-oesophageal junction
Bornschein J. et al, (2021), Best Practice & Research Clinical Gastroenterology, 50-51, 101729 - 101729
Biopsy Sampling in Upper Gastrointestinal Endoscopy: A Survey from 10 Tertiary Referral Centres Across Europe.
Bornschein J. et al, (2021), Digestive diseases (Basel, Switzerland), 39, 179 - 189
Progress in the treatment of cancer patients - don't forget the gut feeling!
Bornschein J. and Brain O., (2020), Best practice & research. Clinical gastroenterology, 48-49
Bright future for endoscopy: the new frontier of gastric cancer secondary prevention
Bornschein J. and Rugge M., (2020), Gut, 69, 1723 - 1724
Neue Horizonte in der Primärdiagnostik des Pankreaskarzinoms
Bornschein J., (2020), Zeitschrift für Gastroenterologie, 58, 693 - 694
EpiCO (epirubicin, cyclophosphamide and vincristine) as treatment for extrapulmonary high-grade neuroendocrine neoplasms
Munker S. et al, (2020), Zeitschrift für Gastroenterologie, 58, 133 - 136
COVID-19: Don’t Neglect the Gastrointestinal Tract!
Malfertheiner P. et al, (2020), Digestive Diseases, 38, 259 - 260
Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study.
Xu Y. et al, (2019), Journal of clinical pathology, 72, 825 - 829
S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs – Langversion 2.0 – August 2019. AWMF-Registernummer: 032/009OL
Moehler M. et al, (2019), Zeitschrift für Gastroenterologie, 57, 1517 - 1632
Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
Bornschein J. et al, (2019), International journal of cancer, 145, 3389 - 3401
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.
Turkington RC. et al, (2019), Gut, 68, 1918 - 1927